Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

2017: The year’s biggest Pharmaceutical Technology stories

Biogen entered a new agreement with Alkermes to develop and commercialise ALKS 8700 to treat multiple sclerosis (MS), while Australia announced $100m of funding to advance brain cancer research in order to provide a better life to people suffering from the disease. Pharmaceutical-technology.com wraps up the key headlines from 2017.

Go Top